Kozak & Associates Inc. Sells 71 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Kozak & Associates Inc. cut its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 3.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,008 shares of the healthcare conglomerate’s stock after selling 71 shares during the period. UnitedHealth Group makes up 0.2% of Kozak & Associates Inc.’s holdings, making the stock its 25th largest position. Kozak & Associates Inc.’s holdings in UnitedHealth Group were worth $1,030,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Hanlon Investment Management Inc. bought a new position in UnitedHealth Group in the second quarter valued at approximately $200,000. Parcion Private Wealth LLC lifted its position in shares of UnitedHealth Group by 22.6% in the second quarter. Parcion Private Wealth LLC now owns 1,500 shares of the healthcare conglomerate’s stock valued at $764,000 after buying an additional 277 shares during the last quarter. Norden Group LLC increased its holdings in UnitedHealth Group by 15.6% in the 2nd quarter. Norden Group LLC now owns 6,080 shares of the healthcare conglomerate’s stock valued at $3,097,000 after buying an additional 820 shares during the period. Umpqua Bank increased its stake in UnitedHealth Group by 3.5% in the second quarter. Umpqua Bank now owns 5,412 shares of the healthcare conglomerate’s stock valued at $2,756,000 after acquiring an additional 184 shares during the last quarter. Finally, Strategic Financial Concepts LLC increased its stake in shares of UnitedHealth Group by 43,843.0% in the 2nd quarter. Strategic Financial Concepts LLC now owns 232,019 shares of the healthcare conglomerate’s stock valued at $118,158,000 after purchasing an additional 231,491 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

UNH traded up $0.32 on Monday, hitting $513.32. 2,141,610 shares of the company’s stock traded hands, compared to its average volume of 3,099,270. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company’s 50 day simple moving average is $559.83 and its 200-day simple moving average is $561.31. The firm has a market cap of $472.40 billion, a price-to-earnings ratio of 33.44, a P/E/G ratio of 1.53 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. During the same period in the previous year, the company posted $6.56 EPS. UnitedHealth Group’s revenue was up 9.2% on a year-over-year basis. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.64%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s payout ratio is currently 54.72%.

Analysts Set New Price Targets

A number of analysts recently weighed in on UNH shares. Truist Financial decreased their price objective on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday. Piper Sandler cut their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday. KeyCorp assumed coverage on UnitedHealth Group in a research report on Friday, October 11th. They issued an “overweight” rating and a $675.00 target price for the company. Morgan Stanley decreased their price objective on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. Finally, HSBC lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 17th. Three analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $627.58.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.